Peter Rossing

@P_Rossing

research.regionh.dk/en/persons/pet… Joined May 2014

391 Following 1.5K Followers 1.1K Posts

Latest posts 5

Peter Rossing @P_Rossing Oct 30, 2024

see the effect of spironolactone wash‐out on albuminuria after long‐term treatment in individuals with type 2 diabetes and high risk of kidney disease—An observational follow‐up of the PRIORITY study - …ibrary-wiley-com.ep.fjernadgang.kb.dk/doi/full/10.11…

Peter Rossing @P_Rossing Oct 30, 2024

No effects of probiotics and fibers on markers of nephropathy, inflammation and intestinal barrier in T1D during a 12w study
sciencedirect.com/science/articl… @Stenodiabetes @buur_stougaard

Peter Rossing @P_Rossing Oct 19, 2024

Endothelial dysfunction markers syndecan-1 and thrombomodulin are associated with higher albuminuria levels in t2d without CVD pubmed.ncbi.nlm.nih.gov/39405782/

pubmed.ncbi.nlm.nih.gov Endothelial dysfunction markers syndecan-1 and thrombomodulin are associated with higher albuminu... We demonstrated an independent association between albuminuria and markers of endothelial function and fibrinogen in individuals with type 2 diabetes and no history of CVD.

Peter Rossing @P_Rossing Oct 19, 2024

Severely increased albuminuria at screening is a powerful criterion for selecting persons with T1D at high risk of kidney function decline.
pubmed.ncbi.nlm.nih.gov/39423023/

Peter Rossing @P_Rossing Sep 1, 2024

See the FINE-HEART
all phase 3 studies with finerenone compiled
rdcu.be/dSC7n